Citius Oncology, Inc. (CTOR)
0.6639
-0.02
(-3.38%)
USD |
NASDAQ |
Apr 07, 16:00
0.6493
-0.01
(-2.20%)
After-Hours: 20:00
Citius Oncology Profit Margin (Quarterly) : -140.3% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Citius Pharmaceuticals, Inc. | -238.2% |
| ACADIA Pharmaceuticals, Inc. | 96.33% |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
| Savara, Inc. | -- |
| BioMarin Pharmaceutical, Inc. | -5.20% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -55.59% |
| Return on Assets | -24.39% |
| Return on Invested Capital | -51.03% |
| Gross Profit Margin (Quarterly) | 79.99% |
| Operating Margin (Quarterly) | -133.2% |
| Return on Net Operating Assets | -24.97% |